In Week 5, you were assigned by Faculty to argue either the pro (for) or con (against) for a particular medication.  You were also provided information for a patient case study scenario. Week 5 was your opportunity to conduct research for this debate.
This week, you will present and defend your assigned stance (pro or con) and specific medication for your patient case study scenario with your peers. Within the debate, you will also share your perspective on why the alternative medication class would not be appropriate for the patient case scenario. 
Support your answers with evidence-based, peer-reviewed scholarly literature.
Note: APA style format with citations and references will apply.
As a reminder, these were the assigned medications:
Pro Con
Amphetamine Amphetamine
Methylphenidate Methylphenidate
Alpha Adrenergic Agonist Alpha Adrenergic Agonist
Non-Stimulant Non-Stimulant
 
Resources

Be sure to review the Learning Resources before completing this activity.
Click the weekly resources link to access the resources. 
WEEKLY RESOURCES
To prepare:
Review the Required Learning Resources.
Review your research regarding your position and medication.
Consider how you will apply your specific position and medication to the presented patient case.
By Day 3 of Week 6
Post your response detailing your argument for the following:
What is the proposed mechanism of action of the medication(s)? Why might this be appropriate for the patients?
What are the advantages or disadvantages to your class of medication (options for different administration, length of duration, etc.)?
What are the advantages or disadvantages to the other medication options?
What possible side effects or considerations need to be evaluated?
Provide one example for each consideration—legal, ethical, and social implications—for prescribing the medication category.
Note: Your response needs to be supported by three 3 scholarly peer-reviewed resources located outside of your course learning resources.

Learning Resources
Readings
Goldin, D. S. (2023). Fast facts for psychopharmacology for nurse practitioners. Springer Publishing.
oChapter 9, “Stimulants/Neurodevelopmental Disorders” (pp. 178–208)
oChapter 10, “Antidementia” (pp. 208–227)
Stahl, S. M. (2021). Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications (5th ed.). Cambridge University Press. 
oChapter 11, “Attention Deficit Hyperactivity Disorder and Its Treatment” (pp. 449–485)
oChapter 12, “Dementia: Causes, Symptomatic Treatments, and the Neurotransmitter Network Acetylcholine” (pp. 486–537)
American Academy of Pediatrics. (2019, October). Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescentsLinks to an external site.. Pediatrics, 144(4), Article e20192528. https://doi.org/10.1542/peds.2019-2528
Drugs.comLinks to an external site.. (2023). https://www.drugs.com/
Note: Please use the following resource to check the most up-to-date box warnings, FDA approvals and indications, recommendations for follow-up evaluations, changes, etc.
CHADD’s National Resource Center on ADHD. (2023). ADHD medications approved by the U.S. Food and Drug Administration: Stimulant medicationsLinks to an external site.. https://d393uh8gb46l22.cloudfront.net/wp-content/uploads/2020/02/ADHD-Medications-Approved-by-FDA-2.23.pdf
Note: Utilize this medication table resource to familiarize yourself with the medications aligned with the topics presented this week.
Media Resources
 

NEI Psychopharm. (2022, March 15). ADHD and comorbidities: What should be treated first?Links to an external site. [Video]. YouTube. https://www.youtube.com/watch?v=f6s-kiMOhE0

Memorable Psychiatry and Neurology. (2022, July 12). Dementia and Alzheimer’s disease mnemonics (Memorable psychiatry lecture)Links to an external site. [Video]. YouTube. https://www.youtube.com/watch?v=q8oj7A38IeU